IFNG and neoplasm: The basic mechanisms of primary drug resistance widely vary, including tumor factors: the expression or inhibition of certain genes and pathways in tumor cells, which prevent immune cells from infiltrating or playing a role in the tumor microenvironment; Tumor cells may inhibit anti-tumor T cell responses; Tumor cell mutations can prevent interference with interferon-γ (IFN-γ).